Autocatalytic phosphorylation of FGFR4 Y367C mutant

Stable Identifier
R-HSA-2012087
Type
Reaction [transition]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Expression of the FGFR4 Y367C mutant in MDA-MB453 breast cancer cell line results in constitutive tyrosine phosphorylation of the receptor and serum-independent activation of downstream signaling as monitored by Erk phosphorylation. Ectopic expression of FGFR4 Y367C in HEK cells also leads to Erk activation and enhanced cellular proliferation. Akt and phospho-AKT levels were not affected by overexpression of the FGFR4 Y367C mutant, however (Roidl, 2010)

Literature References
PubMed ID Title Journal Year
19946327 The FGFR4 Y367C mutant is a dominant oncogene in MDA-MB453 breast cancer cells

Roidl, A, Foo, P, Wong, W, Mann, C, Bechtold, S, Berger, HJ, Streit, S, Ruhe, JE, Hart, S, Ullrich, A, Ho, HK

Oncogene 2010
Participants
Participant Of
Catalyst Activity
Catalyst Activity
Title
protein tyrosine kinase activity of FGFR4 Y367C mutant dimer [plasma membrane]
Physical Entity
Activity
Normal reaction
Disease
Name Identifier Synonyms
breast cancer 1612 malignant tumor of the breast, mammary cancer, malignant neoplasm of breast, mammary tumor, primary breast cancer, breast cancer, Ca breast - NOS, breast tumor
cancer 162 malignant tumor, malignant neoplasm, primary cancer
Authored
Reviewed
Created